X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3401) 3401
Publication (250) 250
Book Review (67) 67
Book Chapter (14) 14
Conference Proceeding (5) 5
Magazine Article (5) 5
Book / eBook (3) 3
Dissertation (2) 2
Web Resource (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2434) 2434
index medicus (1714) 1714
male (1624) 1624
female (1341) 1341
muscarinic antagonists - therapeutic use (1170) 1170
animals (946) 946
middle aged (903) 903
muscarinic antagonists - adverse effects (871) 871
pharmacology & pharmacy (861) 861
aged (791) 791
adult (723) 723
muscarinic antagonists - administration & dosage (723) 723
treatment outcome (710) 710
overactive bladder (556) 556
urinary bladder, overactive - drug therapy (523) 523
urology & nephrology (471) 471
rats (441) 441
muscarinic antagonists - pharmacology (437) 437
efficacy (420) 420
double-blind method (403) 403
pulmonary disease, chronic obstructive - drug therapy (396) 396
neurosciences (395) 395
urinary incontinence (394) 394
dose-response relationship, drug (383) 383
drug therapy (368) 368
double-blind (360) 360
care and treatment (319) 319
time factors (309) 309
analysis (304) 304
respiratory system (304) 304
tolterodine (304) 304
safety (299) 299
tolterodine tartrate (292) 292
aged, 80 and over (285) 285
administration, inhalation (276) 276
drug therapy, combination (274) 274
quality of life (271) 271
copd (263) 263
medicine & public health (256) 256
tiotropium (256) 256
oxybutynin (252) 252
lung diseases, obstructive (250) 250
obstructive pulmonary-disease (247) 247
chronic obstructive pulmonary disease (244) 244
adolescent (239) 239
muscarinic receptors (235) 235
mice (227) 227
quality-of-life (223) 223
urinary incontinence - drug therapy (220) 220
benzhydryl compounds - therapeutic use (214) 214
research (210) 210
bronchodilator agents - administration & dosage (208) 208
pulmonary disease, chronic obstructive - physiopathology (207) 207
acetylcholine receptors (205) 205
muscarinic antagonists (205) 205
medicine, general & internal (203) 203
drugs (193) 193
psychiatry (193) 193
dosage and administration (192) 192
severity of illness index (185) 185
young adult (182) 182
cresols - therapeutic use (180) 180
receptors, muscarinic - drug effects (179) 179
benzhydryl compounds - adverse effects (176) 176
solifenacin succinate (175) 175
urology (175) 175
acetylcholine (172) 172
bronchodilator agents - adverse effects (172) 172
receptors, muscarinic - metabolism (171) 171
bronchodilator agents - therapeutic use (166) 166
clinical trials (165) 165
muscarinic antagonists - pharmacokinetics (165) 165
bladder (163) 163
pharmacology/toxicology (162) 162
tolerability (160) 160
therapy (157) 157
scopolamine (156) 156
prospective studies (155) 155
pharmacokinetics (154) 154
pharmacology (154) 154
incontinence (153) 153
drug administration schedule (152) 152
internal medicine (151) 151
randomized controlled trials as topic (151) 151
health aspects (150) 150
receptors (149) 149
symptoms (149) 149
cross-over studies (148) 148
drug combinations (148) 148
rats, sprague-dawley (148) 148
toxicology (148) 148
asthma (147) 147
management (144) 144
urinary-incontinence (144) 144
solifenacin (141) 141
cresols - adverse effects (139) 139
pulmonary disease, chronic obstructive - diagnosis (137) 137
rats, wistar (137) 137
risk factors (135) 135
adrenergic beta-2 receptor agonists - administration & dosage (133) 133
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3321) 3321
German (41) 41
Russian (12) 12
Spanish (12) 12
French (9) 9
Japanese (8) 8
Chinese (4) 4
Swedish (3) 3
Italian (2) 2
Bulgarian (1) 1
Czech (1) 1
Danish (1) 1
Dutch (1) 1
Finnish (1) 1
Hungarian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 18, pp. 1671 - 1680
The frequency of COPD exacerbations during treatment with a triple inhaler — delivering a long-acting beta-agonist (LABA), a long-acting muscarinic antagonist... 
MEDICINE, GENERAL & INTERNAL | OBSTRUCTIVE PULMONARY-DISEASE | IMPACT | PARALLEL-GROUP | DOUBLE-BLIND | TIOTROPIUM | RANDOMIZED CONTROLLED-TRIAL | FLUTICASONE PROPIONATE/SALMETEROL | SALMETEROL | Glucocorticoids - administration & dosage | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Benzyl Alcohols - administration & dosage | Hospitalization - statistics & numerical data | Male | Dyspnea - etiology | Quinuclidines - administration & dosage | Chlorobenzenes - administration & dosage | Adrenergic beta-Agonists - administration & dosage | Adult | Female | Bronchodilator Agents - adverse effects | Adrenergic beta-Agonists - adverse effects | Glucocorticoids - adverse effects | Double-Blind Method | Drug Administration Schedule | Administration, Inhalation | Pulmonary Disease, Chronic Obstructive - complications | Muscarinic Antagonists - administration & dosage | Androstadienes - administration & dosage | Intention to Treat Analysis | Quality of Life | Dyspnea - drug therapy | Aged | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Treatment outcome | Lung diseases, Obstructive | Care and treatment | Usage | Analysis | Diagnosis | Inhalers | Pneumonia | Acetylcholine receptors (muscarinic) | Glucocorticoids | Lung diseases | Critical care | Fluticasone | Patients | Quality of life | Medicine | Hospitals | Obstructive lung disease | Population | Chronic obstructive pulmonary disease | Drug dosages | Life Sciences | Human health and pathology | Pulmonology and respiratory tract
Journal Article
International Journal of COPD, ISSN 1176-9106, 06/2015, Volume 10, pp. 1015 - 1026
Background: The current Global initiative for chronic Obstructive Lung Disease (GOLD) treatment strategy recommends the use of one or more bronchodilators... 
Clinical trial | agonists | Long-acting muscarinic antagonist | Long-acting β | COPD | clinical trial | COST-EFFECTIVENESS | SAFETY | INHALED CORTICOSTEROIDS | SALMETEROL | FORMOTEROL | OBSTRUCTIVE PULMONARY-DISEASE | PRIMARY-CARE | FLUTICASONE PROPIONATE | RESPIRATORY SYSTEM | DOUBLE-BLIND | TIOTROPIUM | long-acting beta-agonists | long-acting muscarinic antagonist | Bronchodilator Agents - therapeutic use | Indans - adverse effects | Spirometry | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Male | Fluticasone-Salmeterol Drug Combination - therapeutic use | Pulmonary Disease, Chronic Obstructive - physiopathology | Muscarinic Antagonists - therapeutic use | Indans - therapeutic use | Recovery of Function | Fluticasone-Salmeterol Drug Combination - adverse effects | Forced Expiratory Volume | Quinolones - adverse effects | Time Factors | Adrenergic beta-2 Receptor Agonists - adverse effects | Quinolones - therapeutic use | Adrenergic beta-2 Receptor Agonists - therapeutic use | Adult | Female | Surveys and Questionnaires | Indans - administration & dosage | Bronchodilator Agents - adverse effects | Glucocorticoids - adverse effects | Glycopyrrolate - adverse effects | Severity of Illness Index | Pulmonary Disease, Chronic Obstructive - diagnosis | Double-Blind Method | Glycopyrrolate - therapeutic use | Administration, Inhalation | Treatment Outcome | Lung - physiopathology | Glycopyrrolate - analogs & derivatives | Fluticasone-Salmeterol Drug Combination - administration & dosage | Muscarinic Antagonists - administration & dosage | Quinolones - administration & dosage | Glycopyrrolate - administration & dosage | Lung - drug effects | Adrenergic beta-2 Receptor Agonists - administration & dosage | Aged | Nebulizers and Vaporizers | Pulmonary Disease, Chronic Obstructive - drug therapy | Lung diseases, Obstructive | Drug therapy, Combination | Comparative analysis | Drug therapy | Methods | Bronchodilator agents
Journal Article
European Urology, ISSN 0302-2838, 2013, Volume 64, Issue 6, pp. 1003 - 1012
Journal Article